Green Cross

  • Growth Stage
  • Year of Investment: 2017

Green Cross was a pioneer in parenteral nutrition, introducing the first amino acid and fat elision injections to hospitals in China. Currently, Green Cross markets parenteral nutrition injections and an anti-depression product manufactured in its two plants in Guangzhou and Hainan, and imports a microsphere steroid from Mitsubishi Pharma Japan. The company also operates a research center focusing on first-to-market generics, “me-better” products as well as bioequivalence assessment services.